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The in vitro binding of 2000-fold purified rat liver glucocorticoid-receptor complexes to functionally 
differing homologous DNA fractions has been studied. The effectiveness of receptor binding to the 
transcriptionally active DNA, isolated from rat liver 4 h after cortisol administration, increased by 
1.6-l .&fold with simultaneous reduction in receptor affinity for the hardly extractable DNA fraction. The 
analogous DNA fractions from control animals did not differ in ability to bind the receptor. This suggests 
that sites of high affinity for the receptor are directly involved in the in vivo process of hormonal 
transcription activation. 
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1. INTRODUCTION 
The DNA-binding properties of steroid hormone 
receptor are now well-established [l]. A study of 
the interaction of highly purified rat liver ghtcocor- 
ticoid-receptor complexes with DNA and different 
polynucleotides has led us to the conclusion that, 
in addition to the sites of non-specific binding 
(& - 10-3-10-4 M), mammalian DNA contains a 
relatively short sequence whose affinity for receptor 
proteins is higher by several orders of magnitude 
[2,3]. Recent studies showed preferential binding 
of purified glucocorticoid receptor to cloned 
MMTV DNA fragments, whose transcription is 
regulated by glucocorticoids [4-71. Similarly, 
high-affinity sites for purified progesterone recep- 
tor were revealed within hormone-responsive genes 
[8-lo]. Thus, the specificity of transcription modu- 
lation by receptors may be due, at least in part, to 
the recognition of a limited set of DNA sequences. 
binding sites within the functionally different 
homologous DNA fractions in intact as well as 
hormone-treated animals. The in vitro recep- 
tor-DNA binding was performed by an equi- 
librium competitive procedure with an excess of 
DNA-cellulose [2,3]. A tr~s~riptionally active 
DNA fraction isolated from liver of cortisol- 
treated rats showed strongly increased affinity for 
the glucocorticoid receptor. This indicates that (i) 
numerical DNA sites with high affinity for gluco- 
corticoid-receptor complexes are present in the rat 
genome and (ii) these sites are involved in the 
process of the transcription activation by gluco- 
corticoids in vivo. 
2. EXPERIMENTAL 
The aim of our investigation was to examine the 
distribution of hypothetical specific receptor 
Tritium-labeled glucocorticoid-receptor com- 
plexes were prepared by incubation of rat liver 
cytosol (100000 x g, supernatant) with [3H]tri- 
amcinolone acetonide (26 Ci/mmol, Amersham) 
f 11,12]. For receptor purification, a two-step 
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DNA-cellulose binding procedure alternating with 
ammonium sulphate precipitation was employed 
[11,12]. This purification procedure allows us to 
obtain about 2000-fold purified receptor quickly, 
and in a small volume. 
The DNA fractions from rat liver were obtained 
by a modified [ 13,141 salt-phenol treatment pro- 
cedure of intact liver cells [ 151. DNA fraction I was 
extracted by a mixture of 1 M NaCI, 75% phenol 
(pH 6.4); DNA fraction II was subsequently ex- 
tracted by a mixture of 0.14 M NaCl, 66% phenol 
(pH 8.5) and finally for DNA fraction III extrac- 
tion, treatment of the interphase between phenol 
and water with pronase and SDS was needed 
[ 13,141. The quantity of DNA fraction I was highly 
variable and correlated with the amount of active 
chromatin in the nucleus [15,16]. By specific hybri- 
dization tests, fraction I was shown to contain 
15-20-times as much transcribed DNA sequences 
as DNA of other fractions [16,17]. This transcrip- 
tionally active DNA fraction I comprises about 
2O(rlo f the total liver DNA. DNA fraction II 
represents the bulk (>7OVo) of DNA and seems to 
be transcriptionally inactive. DNA fraction III 
amounts to about 10% of the genome, possesses 
low transcription capacity and is obviously associ- 
ated with nuclear membrane components [13,14]. 
The purified DNA fractions were fragmented 
ultrasonically to pieces of an average length of 
250-300bp. These DNA fragments were addi- 
tionally purified by hydroxyapatite chromato- 
graphy and CTAB precipitation [ 181, and redis- 
solved in a solution of 20 mM Tris-HCl (pH 8.1) 
and 1.5 mM EDTA. The base composition and 
main physico-chemical properties of the DNA 
fractions obtained were very similar. The binding 
of purified [3H]triamcinolone-receptor complexes 
to DNA fractions was estimated by DNA-cellulose 
equilibrium competition experiments, as in [2,3]. 
The hydroxyapatite adsorption technique was also 
employed to determine the degree of decomposition 
of the hormone-receptor complexes [2,3]. Radio- 
activity was measured in a Mark III liquid scintilla- 
tion spectrometer (Searle) with a counting efficiency 
of about 33%. 
3. RESULTS AND DISCUSSION 
With the purification procedure employed [l 1,121 
one can obtain 2000-fold purified undegraded re- 
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ceptor. A 5-20% sucrose gradient sedimentation 
of the purified receptor in the presence of 0.4 M 
NaCl revealed a single narrow radioactivity zone 
migrating at about 4 S [ 111. The purified [3H]recep- 
tor yields a single peak when analyzed by gel filtra- 
tion on Sephadex G-150 (fig. 1) or DEAE-cellulose 
chromatography (not shown). This agrees well 
with the known characteristics of rat liver gluco- 
corticoid receptor [ 19-221. However, the purified 
glucocorticoid-receptor complexes were very un- 
stable [4,11]: the radioactivity profile after gel- 
filtration (fig. 1) or sucrose gradient sedimentation 
[I l] revealed a substantial quantity of the released 
hormone. 
Moreover, glucocorticoid-receptor complex 
decay was shown to be not entirely stochastic [3]. 
So, correction for the complex decay provides 
more accurate determination of their amount (olo) 
bound to DNA-cellulose which is important for 
calculation of the relative affinity constant [2,3]. 
Besides, the accounting for hormone-receptor 
stability in each sample substantially reduces the 
role of occasional factors and thus decreases the 
deviation of the values obtained. 
The affinity of the receptor for DNA fractions 
was measured by an equilibrium competitive assay 
procedure [2,3], which is sensitive nough to detect 
small differences in binding effectiveness. The 
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Fig. 1. Sephadex G-150 column chromatography of puri- 
fied rat liver. [3H]Triamcinolone-receptor complexes 
(e) and free [3H]triamcinolone acetonide (0). 
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advantage of this approach is that the receptor 
need not be as highly purified as for electron micro- 
scopy or nitrocellulose filter adsorption assay 
[4-6,8,10]. Our modification of the competition 
assay procedure with the use of a DNA-cellulose 
excess permits competition curves to be linearized 
in a graph of DPM,/DPMi and Rr (fig.2), where 
DPM, is receptor radioactivity bound to DNA-cel- 
lulose in the absence of competitor, and DPMi 
receptor radioactivity bound to DNA-cellulose at 
a given molar ratio Rr of free (competitive) and 
cellulose-coupled nucleic acids. From the slope of 
the straight lines one can readily obtain the relative 
equilibrium binding constant (a) for the nucleic 
acid-receptor interaction [2,3]. 
Fig.2 demonstrates the competition of func- 
tionally different fractions of rat liver DNA plotted 
in the traditional as well as the proposed manner. 
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Fig.2. Competition of rat liver DNA fractions and 
DNA-cellulose for purified glucocorticoid receptor 
binding. The competition of DNA fraction I (o,o), 
fraction II (0, w), and fraction III (A, A) of control 
(open symbols) and cortisol-treated (solid symbols) rats 
is presented in the traditional (upper) as well as in the 
linearized (lower) manner (for details see text and [3]). 
The right and left graphs represent different series of 
experiments. 
The liver DNA fractions were obtained by sequen- 
tial salt-phenol extraction of rat liver cells (see sec- 
tion 2). Three main fractions of high-M, DNA 
were isolated by this method: fraction I, enriched 
by transcriptionally active DNA sequences; frac- 
tion II, representing the bulk of cellular DNA; and 
fraction III, apparently associated with some 
membrane components [ 13- 171. 
Fig.2 (left) shows that all 3 DNA fractions, iso- 
lated from untreated rats, compete to a similar 
extent for receptor binding with DNA-cellulose. 
In contrast, transcriptionally active fraction I, iso- 
lated from cortisol-treated animals, is 1.6-1.8fold 
more effective as a competitor than the other DNA 
fractions (p c 0.01). This means that cortisol- 
responsive genome loci are enriched in specific 
binding sites for immediate inducer, i.e., glucocor- 
ticoid-receptor complexes. Since glucocorticoid- 
induced RNA synthesis in liver proceeds without 
any DNA template amplification [ 181, specific 
receptor-binding sites should translocate to frac- 
tion I from DNA of other fractions, i.e., most of 
all for fraction III, whose binding capacity is re- 
duced after hormone administration (fig.2, right). 
These results are in agreement with the observed 
hormone-induced transfer of some middle repeti- 
tive DNA sequences from fraction III to fraction 
I [ 14,161. RNA/DNA hybridization experiments 
also demonstrated the relative increase in intensity 
of the repeated DNA sequence transcription after 
cortisol administration [23]. So, it is reasonable to 
assume that the rat genome contains multiple high- 
affinity binding sites for glucocorticoid-receptor 
complexes. These sites are localized more or less 
uniformly in the DNA fractions of control rats 
(fig.2), perhaps close to moderately repeated DNA 
sequences. Under cortisol treatment, the receptor- 
binding sites are found mostly in an actively trans- 
cribed DNA/chromatin fraction, whose affinity 
for glucocorticoid-receptor complexes is therefore 
enhanced (fig.2). This is obviously a result of some 
changes in chromatin organization under the in 
vivo hormone action, primarily involving high- 
affinity receptor-binding sites and surrounding 
DNA sequences, including hormone-responsive 
structural genes. Thus, the experimental data here 
are to be considered as a direct indication of the in- 
volvement of specific receptor-binding DNA sites 
in the in vivo process of hormone-induced gene 
activation. 
37 
Volume 165, number 1 FEBS LETTERS January 1984 
REFERENCES 
[l] Yamamoto, K.R. and Alberts, B.M. (1976) Annu. 
Rev. Biochem. 45, 721-746. 
[2] Romanov, G.A., Romanova, N.A., Rozen, V.B. 
and Vanyushin, B.F. (1981) Mol. Biol. (USSR) 15, 
857-814. 
[3] Romanov, G.A., Romanova, N.A., Rozen, V.B. 
and Vanyushin, B.F. (1983) Biochem. Int. 6, 
339-348. 
[4] Payvar, F., Wrange, ii., Carlstedt-Duke, J., 
Okret, S., Gustafsson, J.-A. and Yamamoto, K.R. 
(1981) Proc. Natl. Acad. Sci. USA 78,6628-6632. 
[5] Payvar, F., Firestone, G.L., Ross, S.R., Chandler, 
V.L., Wrange, G., Carlstedt-Duke, J., Gustafsson, 
J.-A. and Yamamoto, K.R. (1982) J. Cell Biochem. 
19, 241-247. 
[6] Govindan, M.V., Spiess, E. and Majors, J. (1982) 
Proc. Natl. Acad. Sci. USA 79, 5157-5161. 
[7] Pfahl, M. (1982) Cell 31, 475-482. 
[8] Compton, J.G., Schrader, W.T. and O’Malley, 
B.W. (1982) Biochem. Biophys. Res. Commun. 
105, 96-104. 
[9] Mulvihull, E.R., LePennec, J.-P. and Chambon, 
P. (1982) Cell 28, 621-632. 
[lo] Compton, J.G., Schrader, W.T. and O’Malley, 
B.W. (1983) Proc. Natl. Acad. Sci. USA 80,16-20. 
[l l] Romanov, G.A., Romanova, N.A., Rozen, V.B. 
and Vanyushin, B.F. (1981) Mol. Biol. (USSR) 15, 
601-612. 
[12] Romanov, G.A. and Vanyushin, B.F. (1982) Bio- 
chim. Biophys. Acta 699, 53-59. 
[13] Dashkevich, V.S. and Arshinova, T.V. (1973) Izv. 
Sib. Otd. Akad. Nauk, SSSR, Ser. Biol. Nauk. 15, 
133-135. 
[14] Dudareva, N.A., Dashkevich, V.S. and Salganik, 
R.I. (1980) Biochimiya 45, 1305-1311. 
[15] Strazhevskaya, N.B. and Struchkov, V.A. (1971) 
Radiobiologiya 11, 649-655. 
[16] Dashkevich, V.S., Dudareva, N.A., Kuzmenko, 
A.P. and Salganik, RI. (1982) in: Molecular 
Mechanisms of Genetic Processes (Dubinin, N.P. 
ed.) pp. 24-30, Nauka, Moscow (in Russian). 
[17] Dashkevich, V.S., Kuzmenko, A.P., Skobeleva, 
N.A., Frolova, L.Yu. and Salganik, R.I. (1983) 
Dokl. Akad. Nauk. SSSR 270, 1236-1238. 
[18] Romanov, G.A. and Vanyushin, B.F. (1981) Bio- 
chim. Biophys. Acta 653, 204-218. 
[19] Wrange, G., Carlstedt-Duke, J. and Gustafsson, 
J.-A. (1979) J. Biol. Chem. 254, 9284-9290. 
[20] Govindan, M.V. and Manz, B. (1980) Eur. J. Bio- 
them. 108, 47-53. 
[21] Nordeen, S.K., Lan, N.C., Showers, M.O. and 
Baxter, J.D. (1981) J. Biol. Chem. 256, 10503- 
10508. 
[22] Simons, S.S. and Thompson, E.B. (1981) Proc. 
Natl. Acad. Sci. USA 78, 3541-3545. 
[23] Vorob’ev, V.I., Konstantinova, I.M. and Kulitch- 
kova, V.A. (1974) FEBS Lett. 47, 39-42. 
38 
